Rare diseases
Investigational molecules
Locations
364 conditions with trials, the busiest first
1 201 trials across Europe, recruiting first
Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera
PolandStudy of G1XCGD Lentiviral Vector in Patients with X-Linked Chronic Granulomatous Disease
FranceStudy on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia
BelgiumStudy of Cusatuzumab and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
SpainStudy on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura
AustriaStudy of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma
FranceStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
FranceStudy of Venetoclax and Azacitidine for Patients with Untreated Acute Myeloid Leukemia Who Cannot Have Standard Induction Therapy
BelgiumStudy Comparing Romiplostim and Dexamethasone with Dexamethasone Alone for Patients with Newly Diagnosed Primary Immune Thrombocytopenia
ItalyStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
AustriaStudy Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
BelgiumStudy on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease
FranceThe therapies tested most often in Blood and lymphatic system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
